Area of research
Public Health, Environmental and Occupational Health · Infectious Diseases
Research interest
Research interests include Malaria Research and Control, Mosquito-borne diseases and control, SARS-CoV-2 and COVID-19 Research, and COVID-19 Clinical Research Studies.
Muco‐Penetrating Lipid Nanoparticles Having a Liquid Core for Enhanced Intranasal mRNA Delivery
Serotonin receptor 5-HT<sub>2A</sub> as a potential target for HCC immunotherapy
The seven enigmas of SARS-CoV-2: From the past to the future
Methylene blue treatment of fatal cerebral malaria and identification of potential blood biomarkers
Design and Characterization of a New Formulation for the Delivery of COVID-19-mRNA Vaccine to the Nasal Mucosa
The artemisinin-induced dormant stages of Plasmodium falciparum exhibit hallmarks of cellular quiescence/senescence and drug resilience
SARS-CoV-2 brainstem encephalitis in human inherited DBR1 deficiency
Crosstalk between CD64+MHCII+ macrophages and CD4+ T cells drives joint pathology during chikungunya
DUSP4 modulates RIG-I- and STING-mediated IRF3-type I IFN response
A common form of dominant human IFNAR1 deficiency impairs IFN-α and -ω but not IFN-β-dependent immunity
Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency
Favorable Preclinical Pharmacological Profile of a Novel Antimalarial Pyrrolizidinylmethyl Derivative of 4-amino-7-chloroquinoline with Potent In Vitro and In Vivo Activities
Positive‐strand RNA viruses—a Keystone Symposia report
Monkeypox: disease epidemiology, host immunity and clinical interventions
Human genetic and immunological determinants of critical COVID-19 pneumonia
Studying severe long COVID to understand post-infectious disorders beyond COVID-19
Autoantibodies against type I IFNs in patients with critical influenza pneumonia
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs
Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose
Decreased memory B cell frequencies in COVID‐19 delta variant vaccine breakthrough infection
Improving in vitro continuous cultivation of Plasmodium cynomolgi, a model for P. vivax
Integrative Genetic Manipulation of <i>Plasmodium cynomolgi</i> Reveals Multidrug Resistance-1 Y976F Associated With Increased In Vitro Susceptibility to Mefloquine
Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individuals
Decoding the Human Genetic and Immunological Basis of COVID-19 mRNA Vaccine-Induced Myocarditis
Generation of self-replicating airway organoids from the cave nectar bat <i>Eonycteris spelaea</i> as a model system for studying host–pathogen interactions in the bat airway epithelium
Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study
Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation
Persistent Symptoms and Association With Inflammatory Cytokine Signatures in Recovered Coronavirus Disease 2019 Patients
COVID-19 vaccines and kidney disease
Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia